Nutraceutical Business Review in conversation with International Health Science

12-Jul-2022

In this exclusive video interview, NBR talks to Professor Francesco de Seta from the University of Trieste. The obstetrics and gynaecology expert discusses UTIs and the varying routes that can be taken to address and prevent, both natural and pharmaceutical

This article is sponsored by International Health Science

In this exclusive video interview, Nutraceutical Business Review talks to Professor Francesco de Seta from the University of Trieste on the topic of female health.

The obstetrics and gynaecology expert discusses UTIs and the varying routes that can be taken to address and prevent them, both natural and pharmaceutical. He specifically discusses Biofarma Group's new supplement for urinary tract infections, the so-called DAPAD that is seeing promising results in new studies.

Recently acquired by Biofarma Group, International Health Science (IHS) is a global leader in developing and offering ready-to-market, private label nutraceuticals, supplements and medical devices.

For more interviews with leading companies from across the nutraceutical industry, visit our YouTube channel and hit subscribe.


Nutraceutical Business Review in conversation with...

'Nutraceutical Business Review in conversation with' is a series of exclusive video interviews with leading companies in the nutraceutical industry, conducted by our team of B2B journalists.


For more information on how you can be part of 'Nutraceutical Business Review in conversation with' contact Gill Healy on +44207 193 1713 or via email at gillh@hpcimedia.com.

This interview was led by Sophie Bullimore from Nutraceutical Business Review.

Sign up for your free email newsletter

Featured Companies